New Jersey 2026-2027 Regular Session

New Jersey Senate Bill S3676

Introduced
2/24/26  

Caption

Permits pharmacists to administer certain long-acting injectable drugs.

Impact

The proposed bill modifies existing regulations concerning the administration of medications by pharmacists, specifically amending P.L.2003, c.280. By allowing pharmacists to administer these injectable medications, the bill potentially increases patient access to care, especially in scenarios where patient visits to physicians may be limited. It also reflects a trend toward optimizing the pharmacist's role within the healthcare system, thus empowering them to play a more significant part in patient treatment plans.

Summary

Senate Bill 3676, introduced in New Jersey, is designed to expand the scope of practice for pharmacists by permitting them to administer specific long-acting injectable drugs. These drugs, which are defined as those approved by the FDA for the treatment or management of psychiatric conditions, can now be administered by pharmacists, provided they have the necessary education and certification as determined by the New Jersey State Board of Pharmacy. This shift aims to improve access to treatment for patients who need long-acting medications, which may be more effective for those with certain psychiatric disorders.

Contention

While the bill may improve patient care, it raises concerns about additional burdens on pharmacists and the training requirements necessary to administer these medications safely. Critics may question whether pharmacists are adequately prepared for this expanded role, especially in managing adverse reactions that can arise from injectable treatments. The ongoing discussion includes considerations about the implications for patient safety, professional boundaries, and the overall healthcare delivery system in New Jersey.

Companion Bills

NJ S4412

Carry Over Permits pharmacists to administer certain long-acting injectable drugs.

Similar Bills

HI HB72

Relating To Pharmacy.

IN HB1571

Pharmacists.

MN SF4486

Pharmacists authorization to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use disorder

MN HF4493

Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.

GA SB195

Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide

MN SF4089

Vaccine administration education and training requirements to prevent shoulder injuries related to vaccine administration establishment and appropriation

MN HF3880

Requirements for education and training on vaccine administration to prevent shoulder injuries related to vaccine administration established, and money appropriated.

IN SB0293

Pharmacist licensure.